Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Exclusive: Sheffield cuts innovative H pylori testing service

In November, Sheffield PCT decommissioned the innovative pharmacy H pylori service, which tested patients for the bacteria that causes dyspepsia and stomach ulcers. If tests proved positive, patients were given treatment for the infection. "The funding was not available" to replace test kits as they ran out, the PCT explained. So are innovative services such as this more likely to be cut? Widely commissioned services such as smoking cessation may prove safer, says Alastair Buxton, PSNC's head of NHS services. "The H pylori service is interesting, but the thing is that stopping smoking is probably a more valuable service for the NHS at the moment," he tells C+D. "The reality of the situation is that it comes down to a cost-benefit analysis by PCTs." Sheffield LPC agrees it came down to cost. "The service was popular but hospitals could do it much cheaper, so it was decommissioned from pharmacies and GPs," LPC secretary James Wood explains. But there are few "safe services" in the current financial climate, Alastair Buxton warns. "I'm not sure any services are safe at the moment," he says. "The challenge is that so many of the services are preventative, and commissioners may decommission them when they're struggling for funding. But that attitude is very short-sighted."#

Find out which PCTs are axing services with C+D's interactive map

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD014307

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel